Do you want to read an article? Please log in or register.
Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial
Asthma
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)